Latest news
{{'2025-09-10T05:00:45Z' | dateFormatFilter}}
Novo Nordisk to streamline operations and reinvest for growth
{{'2025-09-05T06:01:42Z' | dateFormatFilter}}
Novo Nordisk to present new semaglutide data on ‘food noise’, body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress
{{'2025-08-31T07:09:33Z' | dateFormatFilter}}
Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
